1. Home
  2. ATHA vs VNCE Comparison

ATHA vs VNCE Comparison

Compare ATHA & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • VNCE
  • Stock Information
  • Founded
  • ATHA 2011
  • VNCE 2002
  • Country
  • ATHA United States
  • VNCE United States
  • Employees
  • ATHA N/A
  • VNCE N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • ATHA Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • ATHA Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • ATHA 21.0M
  • VNCE 20.2M
  • IPO Year
  • ATHA 2020
  • VNCE 2013
  • Fundamental
  • Price
  • ATHA $0.26
  • VNCE $1.65
  • Analyst Decision
  • ATHA Buy
  • VNCE Strong Buy
  • Analyst Count
  • ATHA 4
  • VNCE 3
  • Target Price
  • ATHA $11.25
  • VNCE $4.33
  • AVG Volume (30 Days)
  • ATHA 204.2K
  • VNCE 36.0K
  • Earning Date
  • ATHA 05-14-2025
  • VNCE 06-17-2025
  • Dividend Yield
  • ATHA N/A
  • VNCE N/A
  • EPS Growth
  • ATHA N/A
  • VNCE N/A
  • EPS
  • ATHA N/A
  • VNCE N/A
  • Revenue
  • ATHA N/A
  • VNCE $293,452,000.00
  • Revenue This Year
  • ATHA N/A
  • VNCE N/A
  • Revenue Next Year
  • ATHA N/A
  • VNCE $5.81
  • P/E Ratio
  • ATHA N/A
  • VNCE N/A
  • Revenue Growth
  • ATHA N/A
  • VNCE 0.19
  • 52 Week Low
  • ATHA $0.22
  • VNCE $1.27
  • 52 Week High
  • ATHA $3.67
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 42.81
  • VNCE 42.84
  • Support Level
  • ATHA $0.23
  • VNCE $1.69
  • Resistance Level
  • ATHA $0.27
  • VNCE $2.49
  • Average True Range (ATR)
  • ATHA 0.03
  • VNCE 0.21
  • MACD
  • ATHA 0.00
  • VNCE 0.02
  • Stochastic Oscillator
  • ATHA 27.53
  • VNCE 8.33

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: